Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : DPP-4 Inhibition and the Path to Clinical Proof - Ahren_2019_Front.Endocrinol.(Lausanne)_10_376 |
| Author(s) : Ahren B |
| Ref : Front Endocrinol (Lausanne) , 10 :376 , 2019 |
| Abstract : Ahren_2019_Front.Endocrinol.(Lausanne)_10_376 |
| ESTHER : Ahren_2019_Front.Endocrinol.(Lausanne)_10_376 |
| PubMedSearch : Ahren_2019_Front.Endocrinol.(Lausanne)_10_376 |
| PubMedID: 31275243 |
| Title : Evidence for neural contribution to islet effects of DPP-4 inhibition in mice - Ahlkvist_2016_Eur.J.Pharmacol_780_46 |
| Author(s) : Ahlkvist L , Omar B , Pacini G , Ahren B |
| Ref : European Journal of Pharmacology , 780 :46 , 2016 |
| Abstract : Ahlkvist_2016_Eur.J.Pharmacol_780_46 |
| ESTHER : Ahlkvist_2016_Eur.J.Pharmacol_780_46 |
| PubMedSearch : Ahlkvist_2016_Eur.J.Pharmacol_780_46 |
| PubMedID: 26997369 |
| Title : Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes - Omar_2014_Diabetologia_57_1876 |
| Author(s) : Omar BA , Liehua L , Yamada Y , Seino Y , Marchetti P , Ahren B |
| Ref : Diabetologia , 57 :1876 , 2014 |
| Abstract : Omar_2014_Diabetologia_57_1876 |
| ESTHER : Omar_2014_Diabetologia_57_1876 |
| PubMedSearch : Omar_2014_Diabetologia_57_1876 |
| PubMedID: 24939431 |
| Title : GLP-1 for type 2 diabetes - Ahren_2011_Exp.Cell.Res_317_1239 |
| Author(s) : Ahren B |
| Ref : Experimental Cell Research , 317 :1239 , 2011 |
| Abstract : Ahren_2011_Exp.Cell.Res_317_1239 |
| ESTHER : Ahren_2011_Exp.Cell.Res_317_1239 |
| PubMedSearch : Ahren_2011_Exp.Cell.Res_317_1239 |
| PubMedID: 21237153 |
| Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE |
| Ref : Diabetes Obes Metab , 13 :775 , 2011 |
| Abstract : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| ESTHER : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedID: 21507182 |
| Title : Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes? - Ahren_2011_Curr.Diab.Rep_11_83 |
| Author(s) : Ahren B |
| Ref : Curr Diab Rep , 11 :83 , 2011 |
| Abstract : Ahren_2011_Curr.Diab.Rep_11_83 |
| ESTHER : Ahren_2011_Curr.Diab.Rep_11_83 |
| PubMedSearch : Ahren_2011_Curr.Diab.Rep_11_83 |
| PubMedID: 21243448 |
| Title : Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes - Alam_2011_Diabetes.Obes.Metab_13_378 |
| Author(s) : Alam ML , Van der Schueren BJ , Ahren B , Wang GC , Swerdlow NJ , Arias S , Bose M , Gorroochurn P , Teixeira J , McGinty J , Laferrere B |
| Ref : Diabetes Obes Metab , 13 :378 , 2011 |
| Abstract : Alam_2011_Diabetes.Obes.Metab_13_378 |
| ESTHER : Alam_2011_Diabetes.Obes.Metab_13_378 |
| PubMedSearch : Alam_2011_Diabetes.Obes.Metab_13_378 |
| PubMedID: 21210936 |
| Title : Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy - Ahren_2010_Diabetes.Care_33_730 |
| Author(s) : Ahren B , Foley JE , Ferrannini E , Matthews DR , Zinman B , Dejager S , Fonseca VA |
| Ref : Diabetes Care , 33 :730 , 2010 |
| Abstract : Ahren_2010_Diabetes.Care_33_730 |
| ESTHER : Ahren_2010_Diabetes.Care_33_730 |
| PubMedSearch : Ahren_2010_Diabetes.Care_33_730 |
| PubMedID: 20067974 |
| Title : Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men - Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| Author(s) : Carr RD , Larsen MO , Jelic K , Lindgren O , Vikman J , Holst JJ , Deacon CF , Ahren B |
| Ref : J Clinical Endocrinology Metab , 95 :872 , 2010 |
| Abstract : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| ESTHER : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| PubMedSearch : Carr_2010_J.Clin.Endocrinol.Metab_95_872 |
| PubMedID: 20008019 |
| Title : Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events - Ahren_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_487 |
| Author(s) : Ahren B |
| Ref : Best Pract Res Clinical Endocrinology Metab , 23 :487 , 2009 |
| Abstract : Ahren_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_487 |
| ESTHER : Ahren_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_487 |
| PubMedSearch : Ahren_2009_Best.Pract.Res.Clin.Endocrinol.Metab_23_487 |
| PubMedID: 19748066 |
| Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE |
| Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009 |
| Abstract : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| ESTHER : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedID: 19174497 |
| Title : Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin - Ahren_2008_Vasc.Health.Risk.Manag_4_383 |
| Author(s) : Ahren B |
| Ref : Vasc Health Risk Manag , 4 :383 , 2008 |
| Abstract : Ahren_2008_Vasc.Health.Risk.Manag_4_383 |
| ESTHER : Ahren_2008_Vasc.Health.Risk.Manag_4_383 |
| PubMedSearch : Ahren_2008_Vasc.Health.Risk.Manag_4_383 |
| PubMedID: 18561513 |
| Title : Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes - Ahren_2008_Expert.Opin.Emerg.Drugs_13_593 |
| Author(s) : Ahren B |
| Ref : Expert Opin Emerg Drugs , 13 :593 , 2008 |
| Abstract : Ahren_2008_Expert.Opin.Emerg.Drugs_13_593 |
| ESTHER : Ahren_2008_Expert.Opin.Emerg.Drugs_13_593 |
| PubMedSearch : Ahren_2008_Expert.Opin.Emerg.Drugs_13_593 |
| PubMedID: 19046129 |
| Title : DPP-4 inhibitors - Ahren_2007_Best.Pract.Res.Clin.Endocrinol.Metab_21_517 |
| Author(s) : Ahren B |
| Ref : Best Pract Res Clinical Endocrinology Metab , 21 :517 , 2007 |
| Abstract : Ahren_2007_Best.Pract.Res.Clin.Endocrinol.Metab_21_517 |
| ESTHER : Ahren_2007_Best.Pract.Res.Clin.Endocrinol.Metab_21_517 |
| PubMedSearch : Ahren_2007_Best.Pract.Res.Clin.Endocrinol.Metab_21_517 |
| PubMedID: 18054733 |
| Title : GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors - Ahren_2007_Curr.Diab.Rep_7_340 |
| Author(s) : Ahren B |
| Ref : Curr Diab Rep , 7 :340 , 2007 |
| Abstract : Ahren_2007_Curr.Diab.Rep_7_340 |
| ESTHER : Ahren_2007_Curr.Diab.Rep_7_340 |
| PubMedSearch : Ahren_2007_Curr.Diab.Rep_7_340 |
| PubMedID: 18173966 |
| Title : Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties - Ahren_2006_Expert.Opin.Investig.Drugs_15_431 |
| Author(s) : Ahren B |
| Ref : Expert Opin Investig Drugs , 15 :431 , 2006 |
| Abstract : Ahren_2006_Expert.Opin.Investig.Drugs_15_431 |
| ESTHER : Ahren_2006_Expert.Opin.Investig.Drugs_15_431 |
| PubMedSearch : Ahren_2006_Expert.Opin.Investig.Drugs_15_431 |
| PubMedID: 16548792 |
| Title : Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice - Ahren_2005_Endocrinology_146_2055 |
| Author(s) : Ahren B , Hughes TE |
| Ref : Endocrinology , 146 :2055 , 2005 |
| Abstract : Ahren_2005_Endocrinology_146_2055 |
| ESTHER : Ahren_2005_Endocrinology_146_2055 |
| PubMedSearch : Ahren_2005_Endocrinology_146_2055 |
| PubMedID: 15604213 |
| Title : Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year - Ahren_2005_Diabetes.Care_28_1936 |
| Author(s) : Ahren B , Pacini G , Foley JE , Schweizer A |
| Ref : Diabetes Care , 28 :1936 , 2005 |
| Abstract : Ahren_2005_Diabetes.Care_28_1936 |
| ESTHER : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedSearch : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedID: 16043735 |
| Title : Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion - Mulder_2004_Diabetes_53_122 |
| Author(s) : Mulder H , Yang S , Winzell MS , Holm C , Ahren B |
| Ref : Diabetes , 53 :122 , 2004 |
| Abstract : Mulder_2004_Diabetes_53_122 |
| ESTHER : Mulder_2004_Diabetes_53_122 |
| PubMedSearch : Mulder_2004_Diabetes_53_122 |
| PubMedID: 14693706 |
| Title : Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes - Ahren_2004_Diabetes.Care_27_2874 |
| Author(s) : Ahren B , Gomis R , Standl E , Mills D , Schweizer A |
| Ref : Diabetes Care , 27 :2874 , 2004 |
| Abstract : Ahren_2004_Diabetes.Care_27_2874 |
| ESTHER : Ahren_2004_Diabetes.Care_27_2874 |
| PubMedSearch : Ahren_2004_Diabetes.Care_27_2874 |
| PubMedID: 15562200 |
| Title : GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes - Ahren_2004_Horm.Metab.Res_36_867 |
| Author(s) : Ahren B , Schmitz O |
| Ref : Hormone & Metabolic Research , 36 :867 , 2004 |
| Abstract : Ahren_2004_Horm.Metab.Res_36_867 |
| ESTHER : Ahren_2004_Horm.Metab.Res_36_867 |
| PubMedSearch : Ahren_2004_Horm.Metab.Res_36_867 |
| PubMedID: 15655721 |
| Title : Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice - Ahren_2000_Eur.J.Pharmacol_404_239 |
| Author(s) : Ahren B , Holst JJ , Martensson H , Balkan B |
| Ref : European Journal of Pharmacology , 404 :239 , 2000 |
| Abstract : Ahren_2000_Eur.J.Pharmacol_404_239 |
| ESTHER : Ahren_2000_Eur.J.Pharmacol_404_239 |
| PubMedSearch : Ahren_2000_Eur.J.Pharmacol_404_239 |
| PubMedID: 10980284 |
| Title : Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells - Mulder_1999_Diabetes_48_228 |
| Author(s) : Mulder H , Holst LS , Svensson H , Degerman E , Sundler F , Ahren B , Rorsman P , Holm C |
| Ref : Diabetes , 48 :228 , 1999 |
| Abstract : Mulder_1999_Diabetes_48_228 |
| ESTHER : Mulder_1999_Diabetes_48_228 |
| PubMedSearch : Mulder_1999_Diabetes_48_228 |
| PubMedID: 9892250 |
| Title : Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes - Bartfai_1993_Proc.Natl.Acad.Sci.U.S.A_90_11287 |
| Author(s) : Bartfai T , Langel U , Bedecs K , Andell S , Land T , Gregersen S , Ahren B , Girotti P , Consolo S , Corwin R , et al. |
| Ref : Proc Natl Acad Sci U S A , 90 :11287 , 1993 |
| Abstract : Bartfai_1993_Proc.Natl.Acad.Sci.U.S.A_90_11287 |
| ESTHER : Bartfai_1993_Proc.Natl.Acad.Sci.U.S.A_90_11287 |
| PubMedSearch : Bartfai_1993_Proc.Natl.Acad.Sci.U.S.A_90_11287 |
| PubMedID: 7504301 |
| Title : Effects of tacrine on insulin secretion and 86Rb+ and 45Ca++ efflux from rat pancreatic islets - Karlsson_1992_J.Pharmacol.Exp.Ther_263_494 |
| Author(s) : Karlsson S , Ahren B |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 263 :494 , 1992 |
| Abstract : Karlsson_1992_J.Pharmacol.Exp.Ther_263_494 |
| ESTHER : Karlsson_1992_J.Pharmacol.Exp.Ther_263_494 |
| PubMedSearch : Karlsson_1992_J.Pharmacol.Exp.Ther_263_494 |
| PubMedID: 1331400 |
| Title : Cholinergic regulation of the endocrine pancreas - |
| Author(s) : Ahren B , Karlsson S , Lindskog S |
| Ref : Prog Brain Res , 84 :209 , 1990 |
| PubMedID: 1702544 |